← Open Payments lookup

GWENDOLYN SHIPE: Open Payments

NPI 1922180322 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,191 in 39 payments from 8 companies in 2025. Trend: 2023 $1,001 · 2024 $719 · 2025 $1,191

Food & beverage: $1,191
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.9$298
Axsome Therapeutics, Inc.7$276
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$234
Corcept Therapeutics5$220
Corium, LLC4$61
Noven Therapeutics, LLC3$51
Vanda Pharmaceuticals Inc.2$33
Lilly USA, LLC1$18

Products named: REXULTI, Auvelity, CAPLYTA, Korlym, Azstarys, Xelstrym, FANAPT, ZEPBOUND.

Industry payments across TX — which companies pay providers there.